LinkedIn Profile

Access Prosetta Biosciences historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:prosettabiosciences 128943 May 31st, 2019 12:00AM Prosetta Biosciences Inc 332 36.00 Open Biotechnology May 31st, 2019 03:39AM May 31st, 2019 03:39AM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Open Open Prosetta Biosciences Inc, 670 5th Street San Francisco California US 94107 Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Mar 19th, 2018 12:00AM Prosetta Biosciences Inc 267 44.00 Open Biotechnology Mar 18th, 2018 08:12PM Mar 18th, 2018 08:12PM Open Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 17th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 16th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 15th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 14th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 13th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 12th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 11th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology
private:prosettabiosciences 128943 Feb 10th, 2018 12:00AM Prosetta Biosciences Inc 253 45.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS). Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods. Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families. Prosetta Biosciences Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.